What short‑acting, non‑sedating sleep aid can be prescribed on an as‑needed (PRN) basis for a 74‑year‑old patient with a history of cancer and bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended Sleep Medication for 74-Year-Old with Cancer and Bleeding History

For this 74-year-old patient with cancer and bleeding history, prescribe trazodone 25 mg PO at bedtime PRN as the safest first-line option. 1

Rationale and Clinical Algorithm

Why Trazodone is Optimal for This Patient

The NCCN Palliative Care Guidelines (2016) specifically list trazodone as the first medication option for insomnia in cancer patients, with a dosing range of 25-100 mg at bedtime 1. This is particularly important for your patient because:

  • Minimal bleeding risk: Trazodone has little to no anticholinergic activity and does not affect platelet function, making it safer in patients with bleeding history 2
  • Cancer-specific evidence: The guidelines were developed specifically for patients with advanced cancer receiving palliative care 1
  • Elderly-appropriate: The 25 mg starting dose is appropriate for a 74-year-old patient
  • PRN use supported: Can be used as-needed without the dependency concerns of benzodiazepines

Alternative Options (in Order of Preference)

If trazodone is ineffective or not tolerated:

  1. Zolpidem 5 mg PO at bedtime 1

    • FDA-mandated lower dose (5 mg, not 10 mg) for elderly patients 1
    • Short-acting, appropriate for sleep-onset insomnia
    • Critical caveat: Warn about next-morning impairment and avoid if fall risk is high
  2. Mirtazapine 7.5-15 mg PO at bedtime 1

    • Particularly useful if patient has comorbid depression or anorexia 1
    • Weight gain may be beneficial in cancer patients with cachexia
    • Sedating at lower doses
  3. Olanzapine 2.5 mg PO at bedtime 1

    • Useful if patient has nausea or delirium as comorbidities
    • Lower metabolic side effects at this dose

What to AVOID in This Patient

Do NOT prescribe benzodiazepines (including lorazepam) despite their listing in guidelines 1. Here's why:

  • The NCCN guidelines explicitly state: "Benzodiazepines should be avoided in older patients and in patients with cognitive impairment, because they have been shown to cause decreased cognitive performance" 1
  • Increased fall risk in elderly patients 3
  • The 2016 guidelines note benzodiazepines cause "decreased cognitive performance" in older adults 1
  • Your patient is 74 years old—this is a critical contraindication

Avoid antihistamines (diphenhydramine, doxylamine):

  • Not recommended due to anticholinergic effects in elderly 2
  • Can worsen confusion and increase fall risk
  • Efficacy not well established 2

Prescribing Instructions

Starting prescription:

  • Trazodone 25 mg tablet
  • Take 1 tablet by mouth at bedtime as needed for sleep
  • Maximum: 1 dose per night
  • Dispense: 30 tablets

Patient counseling points:

  • Take on empty stomach for best effect 2
  • May cause morning grogginess initially—assess tolerance
  • Avoid alcohol
  • May take 30-60 minutes to work

Monitoring and Follow-Up

Reassess within 1-2 weeks:

  • Evaluate sleep quality improvement (not just sleep duration)
  • Screen for daytime sedation or falls
  • If inadequate response at 25 mg, can increase to 50 mg, then 100 mg 1
  • If still ineffective after dose optimization, switch to alternative agent listed above

Important Clinical Caveats

Bleeding history considerations:

  • None of the recommended sleep aids significantly increase bleeding risk
  • Avoid NSAIDs for any concurrent pain management
  • Trazodone does not affect platelet function or coagulation

Cancer-specific considerations:

  • Address underlying contributors: pain, anxiety, depression, nausea 1
  • Consider if corticosteroids or other cancer medications are disrupting sleep 1
  • Non-pharmacologic interventions (sleep hygiene, stimulus control) should be implemented concurrently 1

The evidence base is limited: A 2025 scoping review found that evidence for pharmacological sleep interventions in advanced cancer patients is "extremely limited," with most studies being small and lacking validated assessment tools 4. However, the NCCN guidelines represent the best available consensus for this specific population.

References

Guideline

palliative care version 1.2016.

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

Guideline

clinical guideline for the evaluation and management of chronic insomnia in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

Research

Pharmacological interventions for sleep disturbance ("insomnia") in patients with advanced cancer receiving specialist palliative care: a scoping review.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.